Citability of original research and reviews in journals and their sponsored supplements

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Citrome, Leslie ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIBLIOMETRICS; HUMAN; MEDICAL RESEARCH; PEER REVIEW; PUBLICATION; PUBLISHING;

BIBLIOMETRICS; BIOMEDICAL RESEARCH; HUMANS; JOURNALISM, MEDICAL; PEER REVIEW; PERIODICALS AS TOPIC; PUBLISHING;

EID: 78650771436     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009876     Document Type: Review

References (45)

1. Block AJ (2000) Publishing supplements. Chest 117: 927-928.
2. Anon (1994) Advertising in medical journals and the use of supplements. International Committee of Medical Journal Editors. BMJ 308: 1692.
3. Miller RD (1993) The publication of commercially sponsored supplements. Anesth Analg 77: 651-652.
4. Miller RD (1995) The publication of commercially supported supplements statement. Anesth Analg 81: 886.
5. Yoshikawa TT, Ouslander JG (2006) Supplements to medical journals: adding knowledge or subtracting from the public trust? J Am Geriatr Soc 54: 1-2.
6. Cavalli F (1993) Our policy regarding supplements of sponsored symposia. Ann Oncol 4: 99.
7. Opie LH (1993) The origin and significance of our supplements-a response to the New England Journal of Medicine. Cardiovasc Drugs Ther 7(Suppl 3): 491-492.
8. Picus D (1995) Our first supplement. J Vasc Interv Radiol 6: 839.
9. Lurie P, Newman TB, Hulley SB (1993) Caution over journal supplements. BMJ 307: 1140-1141.
10. Berger M (1998) Commercially sponsored supplements. Diabet Med 15: 85.
11. Kruse MW, Lee JJ (2008) Bias in AJHP supplements. Am J Health Syst Pharm 65: 2328-2329.
12. Kahn JM, Goiten L (2006) Pharmaceutical industry sponsorship of journal supplements. Chest 129: 1387.
13. Jureidini JN (2008) MJA policy on sponsored supplements. Med J Aust 188: 260.
14. Finucane TE (2006) Advertising the new hypnotics. J Am Geriatr Soc 54: 170.
15. Fields D (2006) Response to supplements to medical journals: adding knowledge or subtracting from the public trust? J Am Geriatr Soc 54: 1296.
16. Charatan F (2006) US journal in row over sponsored supplement. BMJ 333: 277.
17. Frisch E (2002) Coxibs supplement: has CCJM sold out? Cleve Clin J Med 69: 568.
18. Wolf R, Wolf D, Ruocco V (1999) Antifungal sponsored supplements. J Am Acad Dermatol 40: 282.
19. Lexchin J (2001) Journal supplements and evidence-based medicine. Can J Clin Pharmacol 8: 162-163.
20. Carlat D (2008) Apparent commercial bias in supplement. J Clin Psychiatry 69: 1010.
21. Carlat D (2009) The Carlat Psychiatry Blog. Available: http://carlatpsychiatry. blogspot.com/search?q= supplement. Accessed 2009 Oct 6.
22. Abramson J (2008) Expert Report of John Abramson, MD. Available: http:// dida.library.ucsf.edu/pdf/oxx18v10. Accessed 2009 Oct 6.
23. Sheldon TA, Smith GD (1993) Consensus conferences as drug promotion. Lancet 341: 100-102.
24. Caelleigh AS (1993) Journal supplements, libraries, and the FDA. Bull Med Libr Assoc 81: 237-239.
25. Rochon PA, Gurwitz JH, Cheung CM, Hayes JA, Chalmers TC (1994) Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA 272: 108-113.
26. Thomson Reuters (2009) ISI Web of Knowledge Web site. Available: http:// www.isiwebofknowledge.com. Accessed 2009 Oct 5.
27. Physicians Postgraduate Press, Inc (2009) Journal of Clinical Psychiatry Web site. http://www.psychiatrist.com. Accessed 2009 Sep 15.
28. American Society of Clinical Psychopharmacology (2009) Web site. Available: http:///www.ascpp.org. Accessed 2009 Sep 15.
29. Physicians Postgraduate Press, Inc (2009) Journal of Clinical Psychiatry Information for Media Planners. Available: http://www.psychiatrist.com/ advertisers/2009%20JCPRateSheet%20050609%20p1.pdf. Accessed 2009 Sep 15.
30. Physicians Postgraduate Press, Inc (2009) Journal of Clinical Psychiatry Masthead. Available: http://www.psychiatrist.com/documents/Masthead.pdf. Accessed 2009 Sep 15.
31. Physicians Postgraduate Press, Inc (2009) Journal of Clinical Psychiatry Reviewers. Available: http://www.psychiatrist.com/documents/reviewers.asp. Accessed 2009 Sep 15.
32. Physicians Postgraduate Press, Inc (2009) CME Institute of Physicians Postgraduate Press, Inc. Policies. Available: http://www.cmeinstitute.com/ documents/policies.asp#. Accessed 2009 Sep 15.
33. Citrome L. Impact Factor? Shmimpact Factor! Psychiatry (Edgmont) 2007;4(May):54-57. Available: http://www.psychiatrymmc.com/impact-factorshmimpact-factor-the-journal-impact-factor-modern-day-literature-searchingand-the-publication-process. Accessed 2009 Sep 15.
34. Seglen PO (1997) Why the impact factor of journals should not be used for evaluating research. BMJ 314: 498-502.
35. Google (2009) Google Scholar beta Web site. Available: http://scholar.google. com. Accessed 2009 Oct 5.
36. Kulkarni AV, Aziz B, Shams I, Busse JW (2009) Comparisons of citations in Web of Science, Scopus, and Google Scholar for articles published in general medical journals. JAMA 302: 1092-1096.
37. Bero LA, Galbraith A, Rennie D (1992) The publication of sponsored symposiums in medical journals. N Engl J Med 327: 1135-1140.
38. Cho MK, Bero LA (1996) The quality of drug studies published in symposium proceedings. Ann Intern Med 124: 485-489.
39. Gami AS, Montori VM, Wilczynski NL, Haynes RB (2004) Author self-citation in the diabetes literature. CMAJ 170: 1925-1927.
40. Daya S (2004) Self-citation and the journal impact factor. Evidence-based Obstetrics and Gynecology 6: 159-160.
41. Fassoulaki A, Paraskeva A, Papilas K, Karabinis G (2000) Self-citations in six anaesthesia journals and their significance in determining the impact factor. Br J Anaesth 84: 266-269.
42. Flanagin A, Carey LA, Fontanarosa PB, Phillips SG, Pace BP, et al. (1998) Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA 280: 222-224.
43. Ross JS, Hill KP, Egilman DS, Krumholz HM (2008) Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA 299: 1800-1812.
44. Sismondo S (2007) Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Med 4: e286.
45. Place F (1934) Ghost writing. Bull Med Libr Assoc 22: 209-213.